Trot Insider has learned that 2011 Elegantimage winner Crys Dream has received a 90-day suspension following a positive test from the June 18 stakes race at Mohawk Racetrack. According to Ontario Racing Commission judge Tom Miller, the test result was received by the ORC yesterday (Tuesday) and harness racing trainer Henrik Hollsten was notified at that time.
Miller told Trot Insider that the 90-day suspension for the horse is in line with suspensions for horses that test positive for a Class 1, 2 or 3 drug, but Miller would not disclose which drug was detected, only stating the drug is a Class 2.
Under RCI guidelines, a Class 2 drug is defined as the following: "Drugs that have a high potential to affect performance, but less of a potential than drugs in Class 1. These drugs are 1) not generally accepted as therapeutic agents in racing horses, or 2) they are therapeutic agents that have a high potential for abuse. Drugs in this class include: psychotropic drugs, certain nervous system and cardiovascular system stimulants, depressants, and neuromuscular blocking agents. Injectable local anesthetics are included in this class because of their high potential for abuse as nerve blocking agents."
Owned by Reve Avec Moi Dreamwithme Stable, Deo Volente Farms LLC, T L P Stable and Jerry Silva, Crys Dream was next slated to compete in the Canadian Breeders Championship in July. If the connections appeal the ruling and ORC Executive Director John Blakney grants a stay, Crys Dream could still race this Summer.
Hollsten and the connections of Crys Dream will meet with the ORC judges on Thursday, June 30, at which time the official paperwork will be served by the ORC. A hearing date to determine penalty for the trainer will be determined at tomorrow's meeting.
from Standardbred Canada
Crys Dream - $519,000 Elegantimage